TRIMBABA — You noted you missed the August HK$80B dilution. Chinese regulatory and geopolitical overhang is structural, not temporary. If you're significantly up, consider trimming to a conviction-sized position. The thesis requires trusting Chinese corporate governance — calibrate size accordingly.
TRIMINTC — Intel is in a multi-year restructuring that could take 3–5 years to resolve. Foundry economics are brutal, market share continues to bleed to AMD/TSMC. No clear catalyst near-term. Unless you have a specific turnaround thesis, trim and redeploy into higher-conviction names.
TRIMMTCH — Match Group (Tinder/Hinge) faces demographic headwinds as Gen Z dating behavior shifts. Revenue declined YoY. The dating app model has limited pricing power vs. free alternatives. Revisit thesis — if no near-term catalyst, trim.
TRIMENPH — Enphase Energy. Residential solar demand has been weak. High interest rates suppress solar installations. The IRA tailwind is real but slow to materialize in margins. Speculative hold at best — trim if overweight relative to conviction.
TRIMWOLF — Wolfspeed (SiC). Capital-intensive, cash-burning, and EV ramp is slower than modeled. Debt is heavy. The SiC thesis is long-term correct but Wolfspeed may not survive to capture it without dilutive financing. Trim to a small speculative size.
TRIMFLYX — flyExclusive. Near NYSE American minimum bid price, negative book equity. The revenue is real ($404M) and operating cash flow is positive, but delisting risk is not zero. Reduce to pure speculation size if not already there.
TRIMSMCI — Super Micro Computer. The business thesis is intact — SMCI is core physical AI infrastructure, building the actual GPU servers that power data centers. The trim flag is purely governance: accounting investigation overhang, auditor resignation, Nasdaq compliance concerns. If/when the investigation resolves cleanly, SMCI moves back to Strong Hold. Until then, size it at a level where the worst-case governance outcome (restatement, fine, prolonged review) doesn't hurt the portfolio materially.
TRIMXPEV — XPeng. Chinese EV in a brutally competitive domestic market with margin wars. BYD is the dominant force and XPeng is fighting for share. Geopolitical risk on top. Keep only if you have high conviction on a specific product cycle catalyst (X9 ramp, ADAS market share).
TRIMOSCR — Oscar Health. Improving financials but still sub-scale for the health insurance market. MLR volatility is the core risk. If you're meaningfully up, taking some off the table is rational. High uncertainty around 2026 ACA enrollment trends.
TRIMETCC — The weakest name in the uranium cluster. If you're managing uranium overexposure, start here. Redeploy into LEU or CCJ — higher quality, more liquid, same theme.
TRIMRXT — Rackspace Technology. Post-bankruptcy capital structure, cloud migration revenue declining as competition intensifies. No obvious catalyst. Trim unless you have a specific private equity / takeout thesis.
TRIMADTN — Adtran Holdings. Broadband/fiber equipment but EU revenue exposure, weak demand from telco capex cuts. High inventory levels. Trim unless you're early in a broadband infrastructure rebound thesis.
TRIMINDI — indie Semiconductor. Auto chip, but EV market slowdown hit auto semis broadly. INDI is burning cash in a down-cycle. Wait for automotive recovery before adding; consider trimming if significantly below cost basis with no near-term catalyst.
TRIMGTX — Garrett Motion. Auto turbocharger exposure; faces headwinds from EV penetration in European markets. Decent FCF but no growth narrative. If you're running this for value, it's fine small. If you expected growth, revisit.
TRIMCLF — Cleveland-Cliffs. Steelmaker with heavy US auto exposure. EV transition pressures steel demand mix. High debt. Cyclical — if macro turns soft, CLF gets hit hard. Trim to a size you'd hold through a recession.
TRIMCENX — Century Aluminum. Aluminum prices are volatile; CENX has high energy cost exposure. The domestic aluminum narrative is real but execution risk is high. Keep small or trim unless you have a strong commodity cycle view.
TRIMPYPL — PayPal. Lost its growth narrative; Braintree is cannibalizing margins; competitive pressure from Apple Pay, Stripe, Affirm. The new CEO's strategy is unproven. Trim unless you're specifically playing a cheap-valuation mean-reversion.
TRIMMOS / NTR — Fertilizer names. Nutrient prices have normalized from the Ukraine war spike. These are cyclical commodity plays — without a specific catalyst (crop failure, supply disruption), there's no urgency to hold overweight. Trim and monitor.
TRIMCLPT — ClearPoint Neuro. Pre-revenue neurosurgery robotics. Compelling long-term story but years from profitability and dependent on capital raises. If you're not sized for maximum dilution risk, trim to pure-speculation size.
TRIMAMPX — Amprius Technologies. Solid-state battery — extremely early stage, no meaningful revenue, cash burn. If this is more than 0.5% of portfolio, that's too heavy for the stage. Trim to a lottery-ticket size.
TRIMBULL — Webull. The China ownership risk is real and structural. Despite strong fundamentals, the stock is near its 52-week low for a reason. Keep only if you're sizing this as a "if China risk resolves" option, not a core holding.